To date, many studies have revealed that neutrophil gelatinase-associated lipocalin (NGAL) has shown promising results in the early diagnosis of AKI [1,2,3,4], distinguishing between prerenal and intrinsic kidney injury ([5,6,7], and predicting the need for renal replacement therapy and prognosis. Here, LCN2 is linked to acute kidney injury.